MagnaPharm Baltics UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
0 |
-25,615 |
-25,615 |
-25,615 |
- |
- |
-20,615 |
117,110 |
0 |
96,495 |
2023 |
---|
814,264 |
183,393 |
-241,519 |
-241,519 |
-54,396 |
56.50 |
-29.66 |
-262,134 |
519,499 |
26,966 |
313,524 |
2024 |
---|
4,648,026 |
690,643 |
12,732 |
-24,488 |
-3,639 |
30.04 |
-0.53 |
713,378 |
1,874,998 |
230,151 |
2,572,721 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
4,648,026 €471 % *
Sales per employee (€)
690,643 €277 % *
Profit before tax (€)
12,732 €105 % *
Net Profit (€)
-24,488 €90 % *
Profit per employee (€)
-3,639 €93 % *
Total profitability (%)
30.04 %-46.83 % *
Net profitability (%)
-0.53 %98.21 % *
Equity (€)
713,378 €372 % *
Amounts Payable And Liabilities (€)
1,874,998 €261 % *
Non-current Assets (€)
230,151 €753 % *
CurrentAssets (€)
2,572,721 €721 % *